BillionToOne
David believes that applying engineering principles to biology will be transformative for medicine. He is the original inventor of the DNA molecular counting platform at BillionToOne and has presented BillionToOne’s clinical trial results at national medical conferences. David has a bachelor’s degree in Physics, cum laude, from Princeton University with minors in Biophysics and Engineering Management Systems. While at Princeton, he was twice awarded the Shenstone Prize in Physics. He received a PhD in bioengineering from Rice University, where he was awarded a Nanobiology training fellowship.
This person is not in any offices
BillionToOne
4 followers
BillionToOne is a precision diagnostics company with the mission to make molecular diagnostics more accurate, efficient, and accessible for all. Our patent-pending molecular counter platform is the only technology platform that can accurately count the DNA molecules to the single-count level.